Texas Children's Celebrates 40th Anniversary of Pioneering Heart Transplant Program
"We are incredibly proud to celebrate the 40th anniversary of our heart transplant program at Texas Children's," said Dr.
Texas Children's Heart Center has been ranked No. 1 in the nation by U.S. News & World Report for eight consecutive years. The multidisciplinary transplant team, integrating more than 40 different subspecialties and services, has transplanted hearts in patients of all ages, from newborns to adults.
Texas Children's patient, 15-month-old Laken, received his new heart last month. He was diagnosed in utero with hypoplastic left heart syndrome (HLHS), and a few months before his first birthday, his family was told that he did not have a chance of survival. After Laken and his family traveled to Texas Children's for a second opinion, our specialized team conducted a detailed evaluation and placed him on the transplant list.
"I couldn't be more thankful for the exceptional care Texas Children's has provided for Laken and for our entire family," said Laken's mother, Whitney. "In addition to saving his life by providing his heart transplant, the team has advocated for him, gotten to know him as an individual and consistently had his best interest in mind."
Over the last decade, Texas Children's Hospital has performed 935 pediatric organ transplants in total, over 100 more transplants than any other pediatric hospital in the nation. In 2023 alone, Texas Children's Hospital Transplant Services team performed 99 organ transplants, outpacing all other children's hospitals by 14 complex surgeries, as reported by the Organ Procurement & Transplantation Network (OPTN), the country's unique public-private registry for organ matching. That same year, Texas Children's celebrated the milestone of transplanting its 550th heart.
"The heart transplant program at Texas Children's Hospital is a wonderful example of the pioneering work in pediatric cardiovascular surgery that Texas Children's Hospital has consistently led for the past 40 years," said Dr.
The multidisciplinary team of experts within the Texas Children's Heart Transplant Program includes pediatric cardiologists, heart transplant surgeons, transplant immunologists, transplant infectious disease experts, transplant coordinators, dietitians, child life specialists, social workers, pharmacists, physical and occupational therapists and more. As the largest volume pediatric heart transplant program in the country, Texas Children's provides patients from all over the world with access to the latest technologies and cutting-edge treatments. For children who need mechanical circulatory support while waiting for a transplant, Texas Children's offers numerous ventricular assist device (VAD) options and extracorporeal membrane oxygenation (ECMO).
"Our heart transplant program is truly exceptional because of our clinical expertise and depth of experience," said Dr. Iki Adachi, Surgical Director, Heart Transplant and Mechanical Circulatory Support at Texas Children's Hospital and Associate Professor of Surgery and Pediatrics at Baylor College of Medicine. "As we celebrate 40 years of saving children's lives, we are dedicated to leading in research and providing the very best specialized care to our patients."
ABOUT TEXAS CHILDREN'S HOSPITAL
Texas Children's, a nonprofit health care organization, is committed to creating a healthier future for children and women throughout the global community by leading in patient care, education and research. Consistently ranked as the best children's hospital in
Media Contact:
818-720-4040 | [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/texas-childrens-celebrates-40th-anniversary-of-pioneering-heart-transplant-program-302317083.html
SOURCE Texas Children's Hospital
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 3Q26
- CMCO Launches 2026 Lifting for the Troops Campaign to Support the Mae and George Siller Tunnel to Towers Foundation Scholarship Program
- FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share